Neuralink, founded by Elon Musk, begins accepting applications for brain implant trials: How to apply and who is eligible? | Global News

Neuralink, the neurotechnology company founded by Elon Musk, is making waves in the medical field with its groundbreaking brain implant technology. After successfully completing over 100 days of clinical trials with its first participant, Neuralink is now inviting applications for its second participant.

The implant, known as the Telepathy cybernetic brain implant, allows individuals to control their phones and computers simply by thinking. This technology has the potential to revolutionize the way paralyzed patients interact with digital devices, giving them newfound independence and control.

To apply for the Neuralink trial, individuals within the United States or Canada who are aged 18 or older and have conditions such as quadriplegia, paraplegia, vision loss, hearing loss, or limb amputation are eligible to participate. Prospective participants can register on the Neuralink website and provide necessary medical information for consideration.

In a recent development, Neuralink faced challenges with the implant’s tiny wires moving out of position during the first human trial. Despite this setback, the company was able to make adjustments and restore the implant’s function, showcasing their dedication to overcoming obstacles and improving their technology.

Overall, Neuralink’s progress in the field of brain-computer interfaces is promising, offering hope for individuals with disabilities to regain control and independence through innovative technology. With Elon Musk at the helm, Neuralink continues to push boundaries and pave the way for a future where the mind can seamlessly interact with technology.